معرفی
Abigail Fahim is an Assistant Professor in the Department of Ophthalmology and Visual Sciences at the University of Michigan Medical School. She is actively affiliated with the UM Kellogg Eye Center and contributes to the Foundation Fighting Blindness Clinical Consortium, a collaboration of 41 international clinical centers managing patients with inherited retinal diseases (IRDs).
Dr. Fahim's research focuses on inherited retinal diseases with particular emphasis on genetic testing disparities across racial groups, choroideremia, Stargardt disease, and USH2A-related retinal degeneration. Her work spans both clinical and basic science domains, investigating genetic detection rates, retinal structure-function relationships, and molecular mechanisms underlying retinal degeneration. She has made significant contributions to understanding why Black patients with IRDs have lower genetic detection rates compared to non-Hispanic White patients.
Analysis of Dr. Fahim's recent publications reveals a strong focus on translational research bridging genetic discoveries with clinical applications. Her work demonstrates expertise in retinal imaging, genetic testing interpretation, and disease progression monitoring. The research spans multiple continents through the Foundation Fighting Blindness Consortium, highlighting her international collaborative approach to tackling inherited retinal diseases.
Dr. Fahim serves on editorial teams for prominent ophthalmology journals including Investigative Ophthalmology & Visual Science, where she co-authored an editorial on supporting effective peer review. Her research is supported through multiple University of Michigan grants and collaborations with the Foundation Fighting Blindness.
She is actively involved with the UM Kellogg Eye Center research team and collaborates extensively with colleagues including Kari Branham, Kanishka Jayasundera, and other members of the Foundation Fighting Blindness Clinical Consortium. Her work combines clinical research with laboratory investigations to advance understanding and treatment of inherited retinal diseases.
